IMEDCO Goes to Kindergarten
It is a privilege for Imedco to be invited by Jakarta Nanyang School (JNY) to share about the process of research and manufacturing of medicine to the kindergarten students. The event was attended by more than 120 students. They are very eager to know how a drug is manufactured.
During the event, Imedco explained that there are various healthcare professionals and one of that is pharmacist who is responsible to dispense and give a consultation about medicine. Imedco further explained that the process to manufacture a drug, is started with a research. A ‘small trial’ on how to create an acceptable formula for children was conducted during the event. Many students were excited to participate in the trial and they created orange and grape flavor syrup. At the same time, we also expose them to various pharmaceutical dosage forms such as tablets and capsules.
This event is aimed to give understanding to the children on how a drug is manufactured and that patient convenience of the medical regime is a factor that we always take into account. We hope that some of them will become good healthcare professionals in the future.
Imedco Djaja Inaugurated by Head of Indonesia National Agency of Drug and Food Control (NADFC)
On 19 December 2016, Imedco Djaja new facility was inaugurated by Head of NADFC Dr. Ir. Penny Kusumastuti Lukito, MCP, represented by Acting Deputy 1 Drs. Ondri Dwi Sampurno M.Si., Apt. In her speech, she addressed that challenges and opportunities are getting higher due to the ASEAN Economic Community and the Indonesian universal health coverage. Therefore, pharmaceutical industry has to meet current Good Manufacturing Process (c-GMP) and up to date with science and technology development. In addition, membership of NADFC in PIC/S also gives an extra benefit for industries to find export opportunities. According to Government Regulation No. 14 in 2015, pharmaceutical industry is one of the prime mover industry and Imedco Djaja as national industry is expected to answer the regional and global challenges. She expressed her deep appreciation in the new management and the total facility renovation.
During this event, Imedco Djaja also facilitated plant visit to see the operation of the new facility. This is to show the commitment of Imedco as partner of NADFC, to comply with all regulation and standards that has been set by the regulators. We believe with our strong commitment, we can meet the regional and global challenges and contribute significantly for Indonesia and many countries.
This inauguration was also attended by representative of Indonesian ministry of health and ex Head of NADFC Dr. Ir. Roy Sparringa, M.App.Sc. and Dra. Kustantinah, Apt., M.App.Sc. We hope through this inauguration, the trust and confidence of entire stakeholders to Imedco Djaja will increase.
WALK IN INTERVIEW
Medical Representative/ Supervisor
If you are interested in marketing and sales career, Imedco Djaja is going to have a “WALK IN INTERVIEW” for Medical representative and sales supervisor on 7 January 2017 from at D’light Restaurant, Jl. Mandala Raya 20 A-B-C, Tomang Jakarta. Please bring your CV if you are interested in this job vacancy.
GP Farmasi Indonesia National Meeting 2016
GP Farmasi Indonesia hold its national congress on 23-25 October 2015 at Trans Luxury Hotel, Bandung with its topic “New Paradigm in the Process of Developing Autonomy Pharmaceutical Business as Nawa Cita (National Priority Agenda)”. Imedco was represented by Suryanto, Audrey Clarissa, and Purwadi Dwijodarmanto.
During the meeting, it was highlighted that Pharmaceutical industry is one of the government priorities as directed by President Jokowi. Therefore, development in pharmaceutical industries will be fully supported by the government. In line with it, pharmaceutical industries and other pharmaceutical businesses should be ready to support the universal health coverage, even though it has its own challenges esp. in pricing. The industrial commission of GP Farmasi Indonesia encourages pharmaceutical industries to play in the “same level playing field”.
In this XV national congress, Mr. F. Tirto Kusnadi was elected as the new Chairperson of GP Farmasi Indonesia 2016-2021. Congratulations to Mr. Tirto in fostering the development of pharmaceutical companies in Indonesia.
Imedco Djaja received the GMP Certificate
Imedco Djaja has received the Good Manufacturing Practice (GMP) Certificates in April 2016 from Indonesia National Agency of Drug and Food Control (NADFC ). The issued certificates cover solid (tablet and capsule), semisolid, and liquid facilities. The certificates were obtained through hard work and team work, and IMEDCO is thankful to have such a dedicated team. We are also grateful for the support of the NADFC who has support us through all the process.
These certificates are a new phase for IMEDCO to impact the Indonesian healthcare. We are committed to produce innovative and high quality products to meet the needs of doctors, pharmacists, and other medical practitioners in serving the community.
Imedco Djaja had been audited by NADFC
In November 2015, Imedco Djaja has completed its total renovation and added new facilities that had taken place since October 2014. Now, Imedco has production facilities for solid, liquid and semisolid products. It is also supported with key facilities such as HVAC and Purified Water System according to the prevailing requirements. These critical facilities are as important as the whole facility inside the production plant; without any of these it is impossible to produce high quality products.
This facility came about as a result of Imedco’s commitment to invest in the country’s infrastructure by modernizing the national pharmaceutical industry and comply with the current national and international regulations. This facility will allow Imedco to meet the growth of local and regional demands for medicines. This in turn, positions Imedco to successfully compete within a new, globalized scenario by fulfilling strong international commitments.
As soon as the renovation and addition of facility has finished, Imedco requested a Good Manufacturing Practices (GMP) audit to the National Agency of Food, Drug, and Cosmetics (NADFC ). The audit took place in the end of November 2015 and we are now progressing for the final review. We will soon be awarded a certificate of Compliance with GMP so that Imedco may start to contribute to the Indonesian healthcare system.